Rafferty Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Sell |
132,021
-39,112
| -23% | -$197K | ﹤0.01% | 831 |
|
|
2025
Q1 | $1.11M | Buy |
171,133
+50,410
| +42% | +$327K | ﹤0.01% | 719 |
|
|
2024
Q4 | $886K | Sell |
120,723
-53,129
| -31% | -$390K | ﹤0.01% | 817 |
|
|
2024
Q3 | $1.3M | Buy |
173,852
+28,005
| +19% | +$210K | ﹤0.01% | 739 |
|
|
2024
Q2 | $1.3M | Sell |
145,847
-293,476
| -67% | -$2.61M | ﹤0.01% | 757 |
|
|
2024
Q1 | $4.45M | Buy |
439,323
+40,353
| +10% | +$409K | 0.02% | 498 |
|
|
2023
Q4 | $4.01M | Sell |
398,970
-126,347
| -24% | -$1.27M | 0.02% | 496 |
|
|
2023
Q3 | $4.92M | Buy |
525,317
+213,477
| +68% | +$2M | 0.03% | 389 |
|
|
2023
Q2 | $7.65M | Buy |
311,840
+10,994
| +4% | +$270K | 0.04% | 300 |
|
|
2023
Q1 | $7M | Sell |
300,846
-7,581
| -2% | -$176K | 0.05% | 294 |
|
|
2022
Q4 | $7.81M | Sell |
308,427
-1,150
| -0.4% | -$29.1K | 0.07% | 270 |
|
|
2022
Q3 | $5.97M | Buy |
309,577
+144,410
| +87% | +$2.78M | 0.06% | 294 |
|
|
2022
Q2 | $4.21M | Sell |
165,167
-79,670
| -33% | -$2.03M | 0.04% | 310 |
|
|
2022
Q1 | $6.3M | Buy |
244,837
+123,896
| +102% | +$3.19M | 0.04% | 314 |
|
|
2021
Q4 | $5.06M | Buy |
120,941
+60,674
| +101% | +$2.54M | 0.03% | 387 |
|
|
2021
Q3 | $2.62M | Buy |
60,267
+2,973
| +5% | +$129K | 0.02% | 549 |
|
|
2021
Q2 | $2.71M | Sell |
57,294
-150,966
| -72% | -$7.14M | 0.02% | 545 |
|
|
2021
Q1 | $10.7M | Buy |
208,260
+158,277
| +317% | +$8.11M | 0.07% | 160 |
|
|
2020
Q4 | $1.34M | Buy |
+49,983
| New | +$1.34M | 0.01% | 458 |
|